Effect of Sleep Apnea on Pain After Dental Treatment
OSA-EndoPain
Relationship Between Obstructive Sleep Apnea and Postoperative Pain After Endodontic Treatment
1 other identifier
observational
78
1 country
1
Brief Summary
This observational study aims to investigate the effects of sleep quality and systemic health status on pain levels following endodontic treatment in adult patients. The primary goal is to determine how obstructive sleep apnea and common systemic conditions (diabetes and hypertension) influence postoperative dental pain. The key questions it aims to answer are: Does the severity of Obstructive Sleep Apnea (OSA) lead to higher postoperative pain scores after root canal treatment? How does the presence of systemic diseases, such as diabetes and hypertension, affect pain perception compared to healthy individuals and OSA patients? Comparison Groups: Researchers will compare outcomes across three distinct cohorts: OSA Group: Patients diagnosed with moderate-to-severe obstructive sleep apnea via polysomnography. Systemic Disease Group: Patients with diagnosed systemic conditions, specifically diabetes and hypertension. Control Group: Systemically healthy individuals without sleep disorders. Participants will: Undergo a polysomnography (PSG) evaluation to assess their sleep status. Receive routine, standard-of-care endodontic treatment. Record and report their pain intensity using the Visual Analog Scale (VAS) at specific intervals after the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedFirst Submitted
Initial submission to the registry
May 6, 2026
CompletedFirst Posted
Study publicly available on registry
May 12, 2026
CompletedMay 12, 2026
May 1, 2026
6 months
May 6, 2026
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pain Intensity measured by Visual Analog Scale (VAS)
Pain intensity is self-reported by patients using a 10-point Visual Analog Scale (VAS), where 0 represents "no pain" and 10 represents "severe pain".
Preoperative (baseline), 6 hours, 24 hours, and 7 days after the endodontic treatment.
Secondary Outcomes (1)
Preoperative Baseline Pain Level
Baseline (Preoperative)
Study Arms (3)
Grup 1 (OSA + Systemic Disease)
Patients diagnosed with moderate (AHI 15-30) or severe (AHI \>30) Obstructive Sleep Apnea (OSA) via polysomnography, who also have systemic diseases such as Diabetes Mellitus and/or Hypertension.
Grup 2 (Systemic Disease Only)
Patients diagnosed with systemic diseases such as Diabetes Mellitus and/or Hypertension, but who do not have Obstructive Sleep Apnea.
Grup 3 (Control Group)
Systemically healthy individuals without any diagnosed systemic diseases or Obstructive Sleep Apnea.
Interventions
Standardized single-session root canal treatment performed under rubber dam isolation and local anesthesia. Root canals are prepared using the VDW.ROTATE™ rotary system, irrigated with 5.25% NaOCl and 17% EDTA, and obturated with the single-cone technique using AH Plus sealer.
Eligibility Criteria
The study population consists of adult patients seeking endodontic treatment at the Harran University Faculty of Dentistry, Department of Endodontics. Participants are selected consecutively from individuals who have undergone polysomnography in an accredited sleep laboratory (for the OSA groups) and from patients with diagnosed systemic conditions such as diabetes and hypertension.
You may qualify if:
- Patients aged between 18 and 65 years.
- Clinical requirement for endodontic (root canal) treatment.
- Presence of a restorable tooth structure.
- Diagnosis of moderate (AHI 15-30) or severe (AHI \> 30) obstructive sleep apnea (OSA) confirmed by polysomnography, for relevant groups.
- Patients with diagnosed systemic diseases (Diabetes Mellitus and/or Hypertension) or systemically healthy controls according to group allocation.
You may not qualify if:
- Presence of periapical lesions identified during preoperative radiographic evaluation.
- Chronic use of analgesics or long-term pain-management medications.
- Pregnancy.
- Failure to complete the established study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Harran University Faculty of Dentristry,Departman of Endodonti
Sanliurfa, Outside of the US, 63300, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 6, 2026
First Posted
May 12, 2026
Study Start
September 15, 2025
Primary Completion
March 15, 2026
Study Completion
March 30, 2026
Last Updated
May 12, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The data will be available starting 6 months after journal publication and will remain accessible for up to 3 years.
- Access Criteria
- De-identified individual participant data can be requested by qualified researchers by emailing the corresponding author for academic and scientific purposes.
Individual participant data (IPD) that are completely de-identified will be shared. This includes demographic information (age and sex), Apnea-Hypopnea Index (AHI) values, systemic health status (diabetes and hypertension status), and preoperative and postoperative Visual Analog Scale (VAS) pain scores. No personally identifying information of the participants will be disclosed to protect patient privacy.